Her work, fostered within an inter-disciplinary research team, focuses on identifying genetic markers for complex metabolic disease and investigating the physiology underlying the identified associations. Future work will extend these findings to examine whether genomic-based nurse-led prevention and treatment strategies that identify individuals most at risk and target the physiologic pathway altered are more effective than current models of care.